Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac fibrosis: Pathobiology and therapeutic targets
Michael P. Czubryt, Taben M. Hale
Cellular Signalling (2021) Vol. 85, pp. 110066-110066
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Progress and prospect of nanotechnology for cardiac fibrosis treatment
Samantha L. Gaytan, Elfa Beaven, Shrikanth S. Gadad, et al.
Deleted Journal (2023) Vol. 1, Iss. 4
Open Access | Times Cited: 25
Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice
Ling Tang, Huiliang Qiu, Bing Xu, et al.
Circulation Research (2024) Vol. 135, Iss. 7, pp. 777-798
Closed Access | Times Cited: 8
Targeted Mitochondrial Function for Cardiac Fibrosis: an Epigenetic Perspective
Peng Liu, Zhenyu Liu, Sui Mao, et al.
Free Radical Biology and Medicine (2025) Vol. 228, pp. 163-172
Closed Access | Times Cited: 1
Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence
Lipeng Shi, Jingwei Deng, Jun He, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176632-176632
Open Access | Times Cited: 7
The role of cardiomyocyte senescence in cardiovascular diseases: a molecular biology update
Shuang-Yi He, Yan Li, Chao Yuan, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176961-176961
Closed Access | Times Cited: 6
Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
Yi Zhu, Yilu Chai, Guojin Xiao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
SGLT-2 inhibitors as novel treatments of multiple organ fibrosis
Jun-Pei Hu, Jianhui Teng, Shan Hui, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29486-e29486
Open Access | Times Cited: 5
20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fibroblasts proliferation and collagen deposition through TGFBR1 signaling pathways
Honglin Xu, Haifeng Miao, Guang‐Hong Chen, et al.
Journal of Ginseng Research (2023) Vol. 47, Iss. 6, pp. 743-754
Open Access | Times Cited: 11
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Patryk Skórka, Jakub Piotrowski, Estera Bakinowska, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
Cardiac implications of chicken wooden breast myopathy
Thea Parsberg Støle, Andreas Romaine, Thea Kleiberg, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Buyang Huanwu Decoction (BYHWD) Attenuates Sepsis-Induced Myocardial Injury by Suppressing Aberrant Iron Accumulation in Preclinical Mouse Models
Lingling Xiao, Jun Lu, Meng Zhao, et al.
Phytomedicine (2025), pp. 156689-156689
Closed Access
Hesperidin improves cardiac fibrosis induced by β-adrenergic activation through modulation of gut microbiota
Xia Liu, Weiwei Ju, Erjiao Qiang, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103578-103578
Closed Access
Activating α7nAChR helps post-myocardial infarction healing by regulating macrophage polarization via the STAT3 signaling pathway
Xiao‐Hui Niu, Ronghua Liu, Xiao Lv, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 879-892
Closed Access | Times Cited: 10
Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis
Azam Hosseinzadeh, Mohammad Hossein Pourhanifeh, Shiva Amiri, et al.
Pharmacological Reports (2023) Vol. 76, Iss. 1, pp. 25-50
Closed Access | Times Cited: 9
Fibroblasts under pressure: cardiac fibroblast responses to hypertension and antihypertensive therapies
Upendra Chalise, Taben M. Hale
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 1, pp. H223-H237
Closed Access | Times Cited: 9
Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway
Shaoling Lin, Shengxi Zhang, Angyu Zhan, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176395-176395
Closed Access | Times Cited: 3
piRNAs as emerging biomarkers and physiological regulatory molecules in cardiovascular disease
Zhihua Liu, Xi Zhao
Biochemical and Biophysical Research Communications (2024) Vol. 711, pp. 149906-149906
Closed Access | Times Cited: 3
Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition
Xingxing Chen, Xue Xia, Tiancheng Dong, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2517-2527
Open Access | Times Cited: 16
Apigenin inhibits isoproterenol‐induced myocardial fibrosis and Smad pathway in mice by regulating oxidative stress and miR‐122‐5p/155‐5p expressions
Feng Wang, Jun Zhang, Guang‐Hao Niu, et al.
Drug Development Research (2022) Vol. 83, Iss. 4, pp. 1003-1015
Closed Access | Times Cited: 14
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
Lipeng Shi, Xuqin Du, Biao Zuo, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 13
Progress of Single-Cell RNA Sequencing Technology in Myocardial Infarction Research
Lanfang Li, Min Wang, Qiuxiao Ma, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Developmental Aspects of Cardiac Adaptation to Increased Workload
B Ošťádal, František Kolář, I Ošťádalová, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 5, pp. 205-205
Open Access | Times Cited: 4
Finding New Targets for the Treatment of Heart Failure: Endoplasmic Reticulum Stress and Autophagy
Leilei Hu, Dongjie Gao, Hao Lv, et al.
Journal of Cardiovascular Translational Research (2023) Vol. 16, Iss. 6, pp. 1349-1356
Closed Access | Times Cited: 4
MicroRNAs and cardiac fibrosis: A comprehensive update on mechanisms and consequences
Zekihan Gocer, Alperen Elek, Halil Caska, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154853-154853
Closed Access | Times Cited: 4
The role of periostin in cardiac fibrosis
Bao Qiao, Xuehao Liu, Bailu Wang, et al.
Heart Failure Reviews (2023) Vol. 29, Iss. 1, pp. 191-206
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top